Zidovudine plus caesarean section reduces HIV transmission risk

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1273, 2001-01, pp. : 16-16

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Zidovudine does not prevent postnatal HIV-1 transmission

By  

Inpharma, Vol. 1, Iss. 1405, 2003-01 ,pp. : 16-16

Adis International

Access to resources Recommend Favorite

Zidovudine + lamivudine to prevent vertical HIV transmission?

By  

Inpharma, Vol. 1, Iss. 1286, 2001-01 ,pp. : 12-12

Adis International

Access to resources Recommend Favorite

Randomised, Multicentre Phase III Study of Saquinavir plus Zidovudine plus Zalcitabine in Previously Untreated or Minimally Pretreated HIV-Infected Patients

By Salgo M.  

Clinical Drug Investigation, Vol. 20, Iss. 5, 2000-11 ,pp. : 295-307

Adis International

Access to resources Recommend Favorite

Mitochondria as Cell Targets of AZT (Zidovudine) - HIV-1 or zidovudine?

By Barile M.   Valenti D.   Quagliariello E.   Passarella S.  

General Pharmacology, Vol. 31, Iss. 4, 1998-10 ,pp. : 531-538

Elsevier

Access to resources Recommend Favorite

Prophylactic lamivudine reduces risk of MTCT of HIV-1 infections

By  

Inpharma, Vol. 1, Iss. 1648, 2008-01 ,pp. : 18-18

Adis International

Access to resources Recommend Favorite